SNC
NVO

Stifel Nicolaus & Co’s Novo Nordisk NVO Stock Holding History

Stifel Nicolaus & Co’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$937K Buy
55,360
+36,290
+190% +$610K 0.02% 686
2013
Q2 		$296K Buy
+19,070
New +$317K 0.01% 1096

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SF
Sarofim Fayez Houston, Texas $20.5B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Stifel Nicolaus & Co's NVO Position: Q3 2013 in Review

Stifel Nicolaus & Co increased its Novo Nordisk (NVO) stake by 190% in Q3 2013, buying an estimated $610K and bringing the position to 55,360 shares worth $937K. The position accounts for 0.02% of the portfolio, ranked #686.

Stifel Nicolaus & Co first reported a position in NVO in Q2 2013 and has held it in 2 quarters since. 425 funds tracked by Wall St. Rank hold NVO as of Q3 2013.

  • Stifel Nicolaus & Co held 55,360 shares of Novo Nordisk worth $937K as of Q3 2013.
  • Stifel Nicolaus & Co bought 36,290 Novo Nordisk shares in Q3 2013, an estimated $610K.
  • Novo Nordisk made up 0.02% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #686 holding.
  • Stifel Nicolaus & Co first reported a position in Novo Nordisk in Q2 2013 and has held it in 2 quarters since.
  • 425 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.